METTL3 and neoplasm: It was observed that in Mettl3-cKO mice, Gr-1+ MDSCs were marginally present in PerC until four to five weeks after ID8 cell inoculation but were dramatically increased in the late phase (eight to nine weeks) of tumor progression (Fig. 3A).